Lineage Cell Therapeutics

LCTX

Börsenwert 246 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
101	101 Thrivent Financial for Lutherans Minneapolis, Minnesota	13.000 $	–	–	–
102	102 WoodTrust Financial Wisconsin Rapids, Wisconsin	13.000 $	–	–	–
103	103 Brown Brothers Harriman & Co New York	12.286 $	–	–	–
104	104 SBI Securities Tokyo, Japan	9.753 $	+428 $	+310	+4 %
105	105 Royal Bank of Canada Toronto, Ontario, Canada	8.000 $	+7.715 $	+5.583	+1.368 %
106	106 Arax Advisory Partners Denver, Colorado	7.700 $	+7.946 $	+5.750	+4.492 %
107	107 Rockefeller Capital Management New York	6.955 $	–	–	–
108	108 Steward Partners Investment Advisory New York	4.978 $	+3.455 $	+2.500	+192 %
109	109 Albion Financial Group Salt Lake City, Utah	3.987 $	–	–	–
110	110 Pacifica Partners Surrey, Canada	3.921 $	–	–	–
111	111 California State Teachers Retirement System (CalSTRS) West Sacramento, California	3.325 $	+3.507 $	+2.538	Neu
112	112 Osaic Holdings Scottsdale, Arizona	2.856 $	-49.898 $	-36.108	-94 %
113	113 Jones Financial Companies Des Peres, Missouri	2.304 $	-3.731 $	-2.700	-60 %
114	114 Harbour Investments Madison, Wisconsin	2.096 $	–	–	–
115	115 Nisa Investment Advisors St. Louis, Missouri	2.082 $	–	–	–
116	116 Trust Company of Vermont Brattleboro, Vermont	2.034 $	+2.146 $	+1.553	Neu
117	117 TD Waterhouse Canada Toronto, Ontario, Canada	1.953 $	–	–	–
118	118 Global Retirement Partners San Rafael, California	1.834 $	+1.935 $	+1.400	Neu
119	119 Wolff Wiese Magana Carslbad, California	1.310 $	–	–	–
120	120 Northwestern Mutual Wealth Management Milwaukee, Wisconsin	1.162 $	–	–	–
121	121 Sterling Capital Management Charlotte, North Carolina	848 $	+894 $	+647	Neu
122	122 Farther Finance Advisors San Francisco, California	713 $	–	–	–
123	123 Allworth Financial Folsom, California	302 $	+287 $	+208	+945 %
124	124 Group One Trading Chicago, Illinois	295 $	-5.349 $	-3.871	-95 %
125	125 Tradewinds Capital Management Bellingham, Washington	294 $	+310 $	+224	Neu

Lineage Cell Therapeutics LCTX Börsenwert 246 Mio. $

Lineage Cell Therapeutics

LCTX

Börsenwert 246 Mio. $